Acumen Pharmaceuticals (ABOS)
(Delayed Data from NSDQ)
$3.54 USD
+0.31 (9.60%)
Updated Jul 23, 2024 04:00 PM ET
3-Hold of 5 3
C Value D Growth F Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $-0.28 | 0.00% |
Earnings Summary
For their last quarter, Acumen Pharmaceuticals (ABOS) reported earnings of -$0.25 per share, missing the Zacks Consensus Estimate of -$0.23 per share. This reflects a negative earnings surprise of 8.70%. Look out for ABOS's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of -$0.28 per share, reflecting no change in earnings compared to the year-ago quarter.
Earnings History
Price & Consensus
Zacks News for ABOS
Acumen Pharmaceuticals (ABOS) Upgraded to Buy: What Does It Mean for the Stock?
ABOS: What are Zacks experts saying now?
Zacks Private Portfolio Services